Gmo Emerging Ntry Fund Return On Equity
| GMCDX Fund | USD 20.89 0.07 0.34% |
Gmo Emerging Ntry fundamentals help investors to digest information that contributes to Gmo Emerging's financial success or failures. It also enables traders to predict the movement of Gmo Mutual Fund. The fundamental analysis module provides a way to measure Gmo Emerging's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gmo Emerging mutual fund.
Gmo |
Gmo Emerging Ntry Mutual Fund Return On Equity Analysis
Gmo Emerging's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Gmo Emerging Ntry has a Return On Equity of 0.0. This indicator is about the same for the GMO average (which is currently at 0.0) family and about the same as Emerging Markets Bond (which currently averages 0.0) category. This indicator is about the same for all United States funds average (which is currently at 0.0).
Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Gmo Fundamentals
| Total Asset | 3.31 B | |||
| Annual Yield | 0.23 % | |||
| Year To Date Return | 13.12 % | |||
| One Year Return | 20.51 % | |||
| Three Year Return | 3.60 % | |||
| Five Year Return | 3.92 % | |||
| Ten Year Return | 7.92 % | |||
| Net Asset | 3.87 B | |||
| Last Dividend Paid | 0.29 |
About Gmo Emerging Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gmo Emerging Ntry's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gmo Emerging using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gmo Emerging Ntry based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Gmo Mutual Fund
Gmo Emerging financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Emerging security.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |